HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

HHS Secretary Tommy G. Thompson has announced four new grants totaling $10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia, four nations that have been hard hit by the AIDS epidemic.

19 Nov 2004

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

AIDS Healthcare Foundation (AHF), today noted that the current "FDA fiasco" involving the agency's initial approval and subsequent recall of Merck's troubled arthritis drug, Vioxx, raises serious questions about the FDA's ongoing parallel role in the approval of generic AIDS drugs for widespread use in Africa and the developing world.

19 Nov 2004

Are HIV infection and personality linked?

Currently, HIV is one of the most widely spread epidemics in the world. The specificity of the mode of transmission, the well-known severity of the prognosis, and the kind of therapies used are peculiarities of this illness.

18 Nov 2004

Biotoxin from puffer fish may provide treatment for opioid withdrawal

On November 10, 2004 investigators involved in a Phase IIa clinical trial of the novel biotoxin Tetrodotoxin (TTX) for the treatment of opioid withdrawal enrolled their first participants.

18 Nov 2004

Low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries

Results of a randomised trial in this week’s issue of THE LANCET highlight how the low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries to help reduce illness and death from opportunistic infections such as pneumonia.

18 Nov 2004

White Paper aims to reduce the number of people who smoke

Health Secretary John Reid today published Choosing Health – the Government’s White Paper on improving public health in England.

16 Nov 2004

Silicone facial implants provide HAART patients with a healthier appearance

Highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS is the name given to treatment regimens recommended by leading HIV experts to aggressively suppress viral replication and progress of HIV disease. These treatment regimens have been shown to reduce the amount of virus so that it becomes undetectable in a patient's blood.

16 Nov 2004

Hep C and HIV among injecting drug users in London are higher than expected

Levels of hepatitis C virus and HIV among injecting drug users in London are higher than expected, according to a study published online by the BMJ.

14 Nov 2004

Better co-ordination crucial to help reduce maternal and child illness and death

The first of a series of articles looking at public health in complex emergencies (such as famine, population movement arising from civil conflicts and associated health problems) is published in this week’s issue of THE LANCET.

14 Nov 2004

HIV drugs known as protease inhibitors also protect against Malaria

Scientists from The Queensland Institute of Medical Research (QIMR) have found that a group of HIV drugs known as protease inhibitors may also be effective for treating or preventing malaria.

11 Nov 2004

Sex genes of infectious fungus closely resemble human Y chromosome

Fungi and animals, including humans, have a lot in common when it comes to the arrangement of genes that determine their sex, according to new work by Howard Hughes Medical Institute geneticists at the Duke University Medical Center.

10 Nov 2004

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria

The study found protease inhibitors inhibited the growth of P. falciparum, the malaria parasite that causes most disease. These findings may also expose a previously unexplored vulnerability in the parasite that could lead to a new class of anti-malarial drug.

8 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

"Does Racial Concordance Between HIV-Positive Patients and Their Physicians Affect the Time to Receipt of Protease Inhibitors?" is published in the November issue of the Journal of General Internal Medicine.

4 Nov 2004

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

The British Medical Association today (4 November 2004) calls on Health Secretary John Reid to deliver tough action to protect the nation's health, as he finalises the White Paper on Public Health for England.

4 Nov 2004

Californians say yes on 71

With a clear mandate, the voters of California yesterday overwhelmingly approved Proposition 71, the California Stem Cell Research and Cures Initiative.

4 Nov 2004

Medmira ships 100,000 rapid HIV tests to China

MedMira has announced that it has shipped 100,000 Rapid HIV Tests to one of its distributors in the People's Republic of China.

4 Nov 2004

Help for NHS staff bringing healthcare to the world's poor

NHS staff from England who are planning health projects in the world's poorest communities are being supported by a new Department of Health fund, now opening its second wave (3 November 2004).

3 Nov 2004

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

In the first study to directly compare the emergence of antibiotic resistance following topical treatment between two antibiotics routinely prescribed for a common vaginal infection, researchers from the Magee-Womens Research Institute have found antibiotic-resistant bacteria more likely to develop with the drug clindamycin than metronidazole.

1 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

HIV/AIDS News and Research

Further Reading

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

Are HIV infection and personality linked?

Biotoxin from puffer fish may provide treatment for opioid withdrawal

Low-cost antibiotic co-trimoxazole should be given to all children with HIV in developing countries

White Paper aims to reduce the number of people who smoke

Silicone facial implants provide HAART patients with a healthier appearance

Hep C and HIV among injecting drug users in London are higher than expected

Better co-ordination crucial to help reduce maternal and child illness and death

HIV drugs known as protease inhibitors also protect against Malaria

Sex genes of infectious fungus closely resemble human Y chromosome

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria

Vaccine contributions to health highlighted at PAHO meeting

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

British Medical Association calls on Health Secretary to deliver tough action to protect the nation's health

Californians say yes on 71

Medmira ships 100,000 rapid HIV tests to China

Help for NHS staff bringing healthcare to the world's poor

Study results suggest that metronidazole and clindamycin differ in their effects on microbes in women with bacterial vaginosis

Cellular enzyme represents a potential new target for developing improved HIV drugs

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News